Smooth Muscle Research Center, Department of Clinical Biochemistry, Copenhagen University Hospital at Koege, Denmark.
Eur J Pharmacol. 2013 Sep 5;715(1-3):312-20. doi: 10.1016/j.ejphar.2013.05.005. Epub 2013 May 21.
Kv7 channels are involved in smooth muscle relaxation, and accordingly we believe that they constitute potential targets for the treatment of overactive bladder syndrome. We have therefore used myography to examine the function of Kv7 channels in detrusor, i.e. pig bladder, with a view to determining the effects of the following potassium channel activators: ML213 (Kv7.2/Kv7.4 channels) and retigabine (Kv7.2-7.5 channels). Retigabine produced a concentration-dependent relaxation of carbachol- and electric field-induced contractions. The potency was similar in magnitude to that of ML213-induced relaxation, suggesting that Kv7.2 and/or Kv7.4 channels constitute the subtypes that are relevant to bladder contractility. The effects of retigabine and ML213 were attenuated by pre-incubation with 10µM XE991 (Kv7.1-7.5 channel blocker) (P<0.05), which in turn confirmed Kv7 channel selectivity. Subtype-selective effects were further investigated by incubating the detrusor with 10µM chromanol 293B (Kv7.1 channel blocker). Regardless of the experimental protocol, this did not cause a further increase in the evoked contraction. In contrast, the addition of XE991 potentiated the KCl-induced contractions, but not those induced by carbachol or electric field, indicating the presence of a phosphatidyl-inositol-4,5-biphosphate-dependent mechanism amongst the Kv7 channels in detrusor. qRT-PCR studies of the mRNA transcript level of Kv7.3-7.5 channels displayed a higher level of Kv7.4 transcript in detrusor compared to that present in brain cortex and heart tissues. Thus, we have shown that Kv7.4 channels are expressed and functionally active in pig detrusor, and that the use of selective Kv7.4 channel modulators in the treatment of detrusor overactivity seems promising.
Kv7 通道参与平滑肌松弛,因此我们认为它们是治疗膀胱过度活动症的潜在靶点。我们使用肌动描记法研究了逼尿肌(即猪膀胱)中 Kv7 通道的功能,目的是确定以下钾通道激活剂的作用:ML213(Kv7.2/Kv7.4 通道)和瑞替加滨(Kv7.2-7.5 通道)。瑞替加滨引起卡巴胆碱和电场诱导收缩的浓度依赖性松弛。其效价与 ML213 诱导的松弛相似,表明 Kv7.2 和/或 Kv7.4 通道构成与膀胱收缩性相关的亚型。瑞替加滨和 ML213 的作用被 10µM XE991(Kv7.1-7.5 通道阻滞剂)的预孵育减弱(P<0.05),这反过来证实了 Kv7 通道的选择性。通过用 10µM 色满醇 293B(Kv7.1 通道阻滞剂)孵育逼尿肌进一步研究了亚型选择性作用。无论实验方案如何,这都不会导致诱发收缩进一步增加。相比之下,XE991 的加入增强了 KCl 诱导的收缩,但不增强由卡巴胆碱或电场诱导的收缩,表明在逼尿肌 Kv7 通道中存在磷脂酰肌醇-4,5-二磷酸依赖性机制。Kv7.3-7.5 通道的 mRNA 转录水平的 qRT-PCR 研究显示,逼尿肌中 Kv7.4 转录本的水平高于大脑皮层和心脏组织。因此,我们已经表明 Kv7.4 通道在猪逼尿肌中表达并具有功能活性,并且使用选择性 Kv7.4 通道调节剂治疗逼尿肌过度活动似乎很有前途。